Chlorthalidone Attenuates the Reduction in Total Cholesterol and Small, Dense LDL Cholesterol Subclass Associated With Weight Loss

Kent Bradley; John M. Flack; John D Belcher; Patricia Elmer; Peggy Miller; Richard Grimm

doi:10.1093/ajh/6.7.636

Chlorthalidone Attenuates the Reduction in Total Cholesterol and Small, Dense LDL Cholesterol Subclass Associated With Weight Loss

Kent Bradley, John M. Flack, John D Belcher, Patricia Elmer, Peggy Miller, Richard Grimm

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Thiazide diuretics are known to raise total and LDL cholesterol. To assess whether chlorthalidone affected levels of putatively atherogenic small, dense LDL (LDL 3), we conducted a 12 week double blind randomized, placebo controlled clinical trial in 34 nonsmoking men aged 35 to 57 years with mild hypertension (DBP 90 to 104 mm Hg). Our a priori hypothesis that chlorthalidone raised LDL 3 levels was not confirmed. However, the fall in LDL 3 (P =.03) and total cholesterol (P =.08) associated with weight loss was attenuated by chlorthalidone. Since weight loss is commonly prescribed during the clinical management of hypertensives with concomitant hypercholesterolemia, consideration should be given to the attenuating effect of chlorthalidone on cholesterol reduction in the management of these patients.

Original language	English (US)
Pages (from-to)	636-639
Number of pages	4
Journal	American journal of hypertension
Volume	6
Issue number	7
DOIs	https://doi.org/10.1093/ajh/6.7.636
State	Published - Sep 1993

Bibliographical note

Funding Information:
This work was supported in part by Biomedical Research Grant (BRSG) #096-5725-95, the Ruben Miller Cardiovascular Fund, and National Heart, Lung, and Blood Institute/National Institutes of Health grants N01 HV48048 and R01 HL34767.

Keywords

Chlorthalidone
Clinical trial
LDL cholesterol subclasses
Weight loss

Access

10.1093/ajh/6.7.636

Cite this

Chlorthalidone Attenuates the Reduction in Total Cholesterol and Small, Dense LDL Cholesterol Subclass Associated With Weight Loss. / Bradley, Kent; Flack, John M.; Belcher, John D; Elmer, Patricia; Miller, Peggy; Grimm, Richard.

In: American journal of hypertension, Vol. 6, No. 7, 09.1993, p. 636-639.

Research output: Contribution to journal › Article › peer-review

@article{ec2d433c5aae4ec88baa3414491d14fd,

title = "Chlorthalidone Attenuates the Reduction in Total Cholesterol and Small, Dense LDL Cholesterol Subclass Associated With Weight Loss",

abstract = "Thiazide diuretics are known to raise total and LDL cholesterol. To assess whether chlorthalidone affected levels of putatively atherogenic small, dense LDL (LDL 3), we conducted a 12 week double blind randomized, placebo controlled clinical trial in 34 nonsmoking men aged 35 to 57 years with mild hypertension (DBP 90 to 104 mm Hg). Our a priori hypothesis that chlorthalidone raised LDL 3 levels was not confirmed. However, the fall in LDL 3 (P =.03) and total cholesterol (P =.08) associated with weight loss was attenuated by chlorthalidone. Since weight loss is commonly prescribed during the clinical management of hypertensives with concomitant hypercholesterolemia, consideration should be given to the attenuating effect of chlorthalidone on cholesterol reduction in the management of these patients.",

keywords = "Chlorthalidone, Clinical trial, LDL cholesterol subclasses, Weight loss",

author = "Kent Bradley and Flack, {John M.} and Belcher, {John D} and Patricia Elmer and Peggy Miller and Richard Grimm",

note = "Funding Information: This work was supported in part by Biomedical Research Grant (BRSG) #096-5725-95, the Ruben Miller Cardiovascular Fund, and National Heart, Lung, and Blood Institute/National Institutes of Health grants N01 HV48048 and R01 HL34767.",

year = "1993",

month = sep,

doi = "10.1093/ajh/6.7.636",

language = "English (US)",

volume = "6",

pages = "636--639",

journal = "American Journal of Hypertension",

issn = "0895-7061",

number = "7",

}

TY - JOUR

T1 - Chlorthalidone Attenuates the Reduction in Total Cholesterol and Small, Dense LDL Cholesterol Subclass Associated With Weight Loss

AU - Bradley, Kent

AU - Flack, John M.

AU - Belcher, John D

AU - Elmer, Patricia

AU - Miller, Peggy

AU - Grimm, Richard

N1 - Funding Information: This work was supported in part by Biomedical Research Grant (BRSG) #096-5725-95, the Ruben Miller Cardiovascular Fund, and National Heart, Lung, and Blood Institute/National Institutes of Health grants N01 HV48048 and R01 HL34767.

PY - 1993/9

Y1 - 1993/9

N2 - Thiazide diuretics are known to raise total and LDL cholesterol. To assess whether chlorthalidone affected levels of putatively atherogenic small, dense LDL (LDL 3), we conducted a 12 week double blind randomized, placebo controlled clinical trial in 34 nonsmoking men aged 35 to 57 years with mild hypertension (DBP 90 to 104 mm Hg). Our a priori hypothesis that chlorthalidone raised LDL 3 levels was not confirmed. However, the fall in LDL 3 (P =.03) and total cholesterol (P =.08) associated with weight loss was attenuated by chlorthalidone. Since weight loss is commonly prescribed during the clinical management of hypertensives with concomitant hypercholesterolemia, consideration should be given to the attenuating effect of chlorthalidone on cholesterol reduction in the management of these patients.

AB - Thiazide diuretics are known to raise total and LDL cholesterol. To assess whether chlorthalidone affected levels of putatively atherogenic small, dense LDL (LDL 3), we conducted a 12 week double blind randomized, placebo controlled clinical trial in 34 nonsmoking men aged 35 to 57 years with mild hypertension (DBP 90 to 104 mm Hg). Our a priori hypothesis that chlorthalidone raised LDL 3 levels was not confirmed. However, the fall in LDL 3 (P =.03) and total cholesterol (P =.08) associated with weight loss was attenuated by chlorthalidone. Since weight loss is commonly prescribed during the clinical management of hypertensives with concomitant hypercholesterolemia, consideration should be given to the attenuating effect of chlorthalidone on cholesterol reduction in the management of these patients.

KW - Chlorthalidone

KW - Clinical trial

KW - LDL cholesterol subclasses

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=0027182440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027182440&partnerID=8YFLogxK

U2 - 10.1093/ajh/6.7.636

DO - 10.1093/ajh/6.7.636

M3 - Article

C2 - 8398006

AN - SCOPUS:0027182440

VL - 6

SP - 636

EP - 639

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 7

ER -

Chlorthalidone Attenuates the Reduction in Total Cholesterol and Small, Dense LDL Cholesterol Subclass Associated With Weight Loss

Abstract

Bibliographical note

Keywords

Access

Other files and links

Fingerprint

Cite this